ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,477.90
0.16%
Dow Jones
39,127.80
0.04%
US Dollar vs MXN
18.3247
1.09%
Brent Oil
84.47
0.34%
Bitcoin
60,765.04
-1.69%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
26/06/202418:46PR Newswire (Canada)Government of Canada launches public consultation on artificial intelligence computing infrastructure
26/06/202418:45GlobeNewswire Inc.Announcement Regarding Filing of Annual Report on Form 20-F with the U.S. Securities and Exchange CommissionNYSE:MFGMizuho Financial Group Inc
26/06/202418:45Business WirePatritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party ManufacturerNYSE:MRKMerck and Co Inc
26/06/202418:43Business WireTakeda kündigt neue Besetzung der Direktorenposten anNYSE:TAKTakeda Pharmaceutical Company Ltd
26/06/202418:43Business WireTamboran Prices US IPO at US$24.00 Per ShareASX:TBNTamboran Resources Ltd
26/06/202418:31Business WireCognite reconnue comme partenaire de l'année 2024 de Microsoft en matière d'énergie et de ressources
26/06/202418:31Business WireCognite reconhecida como o Parceiro do Ano em Energia e Recursos da Microsoft em 2024
26/06/202418:30NEWSBTCDogecoin Sees Rapid Accumulation Amid Price Crash, Whale Transactions SoarCOIN:SHIBUSDSHIBA INU
26/06/202418:30Business WireChewy Announces $500 Million Repurchase of Shares from BC PartnersNYSE:CHWYChewy Inc
26/06/202418:27PR Newswire (Canada)Laramide Resources Announces Voting Results from its Annual Meeting of ShareholdersTSX:LAMLaramide Resources Ltd
26/06/202418:26PR Newswire (Canada)METALLA ANNOUNCES VOTING RESULTS FROM ANNUAL GENERAL MEETINGTSXV:MTAMetalla Royalty and Streaming Ltd
26/06/202418:25Business WireTakeda annonce de nouvelles nominations de directeursNYSE:TAKTakeda Pharmaceutical Company Ltd
26/06/202418:23GlobeNewswire Inc.Else Nutrition Announces US$2 Million Offering of Units Priced At-The-MarketTSX:BABYElse Nutrition Holdings Inc
26/06/202418:18GlobeNewswire Inc.NASP Applauds the Senate Finance Chairman for Working to Address Unfair PBM Practices
26/06/202418:18Business WireArvest Bank and the Federal Home Loan Bank of Dallas Celebrate $15K Donation to Assist Affordable Housing Nonprofit
26/06/202418:12PR Newswire (Canada)Revised - Medical Facilities Corporation Announces Second Quarter DividendTSX:DRMedical Facilities Corporation
26/06/202418:08Business WireEPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)NASDAQ:GMABGenmab AS
26/06/202418:08PR Newswire (US)Harbour BioMed Announces Resubmission of Biologics License Application for Batoclimab to NMPA for Treatment of Generalized Myasthenia Gravis
26/06/202418:05PR Newswire (US)2bcloud Recognized as Winner of 2024 Microsoft Partner of the Year Award
26/06/202418:05GlobeNewswire Inc.Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone4565.T
26/06/202418:03PR Newswire (US)U.S. Food and Drug Administration Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Patients with Relapsed or Refractory Follicular LymphomaNYSE:ABBVAbbVie Inc
26/06/202418:01PR Newswire (US)Global IPO divergence widens as Americas and EMEIA surge and Asia-Pacific slows
26/06/202418:01PR Newswire (Canada)Avis aux médias - Itinéraire du premier ministre pour le jeudi 27 juin 2024
26/06/202418:00Business WireEnhance Your Garden Maintenance with the Yard Force LSC18-JP at Yard Force Japan
26/06/202418:00GlobeNewswire Inc.PyroGenesis Provides Update Regarding Receipt of $4.1 Million Payment8PY
26/06/202418:00Business WireSamsung Unveils Versatile Image Sensors for Superior Smartphone Photography
26/06/202418:00Business WireNeuer Cloudflare-Report: Unternehmen setzen auf veraltete Sicherheitskonzepte, während Onlinebedrohungen zunehmenNYSE:NETCloudflare Inc
26/06/202418:00CointelegraphJapanese village turns to NFTs to help older adultsCOIN:BTCUSDBitcoin
26/06/202417:59Business WireLA Kings Officially Introduce New Home and Away Uniforms
26/06/202417:58PR Newswire (Canada)Media Advisory - Prime Minister's itinerary for Thursday, June 27, 2024

Su Consulta Reciente

FX
USDMXN
US Dollar vs MXN
AMEX
SPY
SPDR S&P 500
USOTC
ADDYY
Adidas (QX)
NYSE
VZ
Verizon Communications
COIN
ETHUSD
Ethereum
CCOM
SILVER
SILVER
FX
EURUSD
Euro vs US Dollar
AMEX
XLE
Energy Select Sector SPDR
NYSE
CVX
Chevron
USOTC
RHHBY
Roche (QX)
NASDAQ
AMZN
Amazon.com
NYSE
JPM
JP Morgan Chase
AMEX
XLV
Health Care Select Sector
USOTC
BASFY
BASF (QX)
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados